chrisvoncsefalvay/vaers-outcomes huggingface dataset:
Migraine that lasted for 30 hours straight at 8/10 pain, no sleep, no relief.  Treatment was lying in bed.  Since then migraine episodes more frequent and more painful.  I have had to leave work early on more than one occasion due to the severity of migraine symptoms.
Client received the 1st dose of Moderna COVID vaccine lot # 017C21A and expiration date 5/23/21 at 11:45am.  Client reports to EMT  that she feels dizzy and has already been sitting for 15 minutes. At 12pm vitals: blood pressure:149/86, oxygen:99%, and pulse 52.  PHN  found client sitting upright in chair alert and oriented x 4.  Client reports having a history of high blood pressure and took medication this morning. Client takes bisprolol 1.25mg and vitamins.  Vitals: blood pressure:116/66,oxygen: 99%, and pulse:67. Last set of vitals taken at 12:30pm: blood pressure: 122/69, oxygen:98%, and pulse:75.    PHN educated client on worsening signs and symptom of vaccine side effect and when to seek help by EMS. Client verbalized understanding of education.  Client left facility unassisted with a steady gait at 12:32pm.
arm is still sore/sore arm; This is a spontaneous report received from a contactable reporter(s) (Consumer or other non HCP) from medical information team. The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), on 25Oct2022 as dose number unknown (booster), single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. Vaccination history included: Covid-19 vaccine (Primary Immunization series complete; unknown manufacturer), for COVID-19 immunisation. The following information was reported: PAIN IN EXTREMITY (non-serious) with onset 2022, outcome "not recovered", described as "arm is still sore/sore arm".  Additional information included as patient got the Pfizer BioNTech COVID booster and said one side effect was sore arm, received vaccine 25Oct2022, arm is still sore. She wanted to know how long will this last. She has an appointment shortly, calling to see how long these side effects last because has to go do bloodwork soon. Patient reported that she is having a sore arm since she received the Pfizer-BioNTech Covid 19 Vaccine booster shot (no formulation was specified).   No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.
CHILLS, FEVER, DRY MOUTH DRY, COUGH, ACHES, PAINS, NO TASTE, AND EXTREME TIREDNESS SINCE THEN.
Five minutes after receiving the vaccination on her left arm, she developed nausea and lightheadedness and weakness. No vomiting or syncope. She was escorted to a private session of the arena and monitored. Her initial blood pressure was 140/80. She was given water to drink and ate an apple.
Information has been received from a licensed practical nurse concerning an 8 year old female patient who on 01/27/97 was vaccinated with Varivax. On 12/27/01, the patient presented to her pediatrician's office with several varicella lesions It was reported that the child had some lesions on her legs, a few on her trunk, and one on her face. The child subsequently recovered. The nurse also reported that a 7 year old male developed varicella following vaccination with Varivax (WAEs0201USA00230). No further information is available.
took the shots and I got shingles / suspected vaccination failure; shingles; This case was reported by a consumer via interactive digital media and described the occurrence of suspected vaccination failure in a patient who received Herpes zoster (Shingles vaccine) for prophylaxis.   Co-suspect products included Herpes zoster (Shingles vaccine) for prophylaxis.   On an unknown date, the patient received the 2nd dose of Shingles vaccine and the 1st dose of Shingles vaccine. On an unknown date, unknown after receiving Shingles vaccine and Shingles vaccine, the patient experienced vaccination failure (serious criteria GSK medically significant) and shingles. On an unknown date, the outcome of the vaccination failure and shingles were unknown.   It was unknown if the reporter considered the vaccination failure and shingles to be related to Shingles vaccine and Shingles vaccine.  Additional case details were reported as follows: The reporter was patient itself. The age at vaccination was not reported. The patient took the shots and still got shingles. This case was considered as suspected vaccination failure, as details regarding laboratory test confirmation and time to onset for shingles were unknown at the time of reporting. The follow up was not required.
Provider ordered initial covid vaccine and patient received Bivalent Pfizer booster dose instead. Employee notified manager. Manager notified provider and pharmacist. Information received from both Department of Public Health and Manufacture - "If a bivalent Pfizer-BioNtech vaccine is administered for primary series dose: Do not repeat the dose. The primary and booster dosages are the same; the bivalent dose can be counted as a primary series dose. Continue with the recommended vaccination schedule: (iel, complete the primary series with a monovalent Pfizer-BioNTech vaccine, then administer a bivalent booster dose at least 2 months after completion of the primary series." All information provided.  No adverse reactions noted.  No adverse reactions at this time.
Pain when raising arm, ROM, weakness at certain spots, heat, Tylenol, Mortin.
Hep A, MCV4, TIV given on 10-21-13. Ultrasound result from 11-14-13 confirmed that patient was 5 weeks, 6 days pregnant, patient stated at time of visit that she was not sexually active.
Subsequent to receiving one dose of varicella virus vaccine live the pt experienced chickenpox which began as one spot on the shoulder then progressed to a rash with approximately 100-150 lesions. The pt had red papules on the trunk, groin and scalp. The pt had no fever and felt fine.
"About 2 hours after vaccine administration experienced severe fatigue. Went home and took 2 hour nap. Was still somewhat fatigued through the evening. Felt fine when waking up the next day."
Headache, nausea, stomach cramps.  Still today as of Dec 5 th 2016 still having all day intense headaches and intermittent nausea.
pt recvd flu vax & exp vertigo 1/2 hr later which lasted for 3 to 4 hrs; the next day devel 4" hive described as like cellulitis which was erythematous & warm to the touch; also had pain in the axilla;
The following day I had a very sore shoulder with severe flu symptoms. I slept many hours during the day. Shoulder pain was so severe that I was unable to use the shoulder for about 3 weeks.
upper back, neck and should pain; upper back, neck and should pain; upper back, neck and should pain; This is a spontaneous report received from non-contactable reporter(s) (Physician). The reporter is the patient.  A female patient received BNT162b2, BNT162b2 omi ba.4-5 (BNT162B2, BNT162B2 OMI BA.4-5), as dose number unknown, single (Batch/Lot number: unknown) for covid-19 immunisation. The patient's relevant medical history and concomitant medications were not reported. The following information was reported: BACK PAIN (non-serious), NECK PAIN (non-serious), ARTHRALGIA (non-serious), outcome "unknown" and all described as "upper back, neck and should pain".  Additional information: Physician reported that she as well as others she knew (patients, friends, family members) had experienced continued upper back, neck and shoulder pain since receiving the COVID vaccine, irrespective of manufacturer.  The information on the batch/lot number for BNT162b2, BNT162b2 omi ba.4-5 has been requested and will be submitted if and when received.
This spontaneous report as received from a pharmacist refers to a 66 year old female patient. The reaction was described as itching and hurts. Pertinent medical history was unspecified by the reporter. On MAY-1993 (20 years ago), the patient was vaccinated with a dose of (manufacturer unknown) injection (lot number, expiration date, route and dose were not reported). On approximately May 2013, the patient had an allergic reaction to a "pneumonia vaccine" and pneumococcal vaccine, polyvalent (23-valent) (manufacturer unknown) could not be ruled out. The patient experienced high fever of 104.6F, she felt as if she had the flu, and there was approximately a 4 inch area at the site of injection. The site was hot, swollen and very sore. After the third day, on an unspecified date, the redness, swelling and pain started to dissipate and were eventfully gone. Pharmacist also stated that the patient had a reaction to neomycin in the past. Patient's status was reported as recovered. No treatment was given. It was not reported if the patient sought medical attention. Additional information has been requested.
Information has been received from a pharmacist who is also a clinician who in 2005 was vaccinated with a dose of Pneumovax 23.  In 2005 the patient developed swelling at the injection site (outcome not reported).  On 15-DEC-2006 while administering a dose of Pneumovax 23 (lot #651330/1048P) the plunger separated from the needle and the vaccine splashed in his face and right eye.  Subsequently his right eye became blurry.  Unspecified medical attention was sought.  He washed his right eye with water.  At the time of the report, the patient's blurred vision persisted.  Additional information is not expected.
Extreme dizziness migraine for a week now chills lethargy, Confusion blurred vision vomiting nausea muscle soreness, shortness of breath feeling like my lungs are sick sore throat congestion coughing up phlegm
Rash erythematous. A physician reports that a pt received 2nd dose of Prevnar and Engerix B vaccines on 3/23/01, within 12 hrs post IZ he developed a generalized erythematous rash, irritability, sleeplessness, and a decreased appetite. The reporter indicated that the pt did not sleep for 3 nights. A copy of this report has been forwarded to SKB.
This spontaneous case, initially received on 05-Oct-2018, from other non-health professional (consumer), concerns a 53-year-old, adult, female patient. It was reported that the patient never had a reaction to flu shots in past. The patient's historical drug included medroxyprogesterone a five-day course which stopped on 03-Oct-2018 (Wednesday as reported). The patient was allergic to sulfa and penicillin. The patient's concomitant medications included SYNTHROID, KLOR-CON m20, propranolol (extended release), fluoxetine HCL, Triamterene/HCTZ and multivitamins for unknown indications. On 05-Oct-2018, at 08:35 am, the patient was administered FLUCELVAX QIVc [dose: 0.5 ml, route of administration: intramuscular, anatomical location: deltoid, batch number: 252227 and expiry date: 31-May-2019]. The Seqirus Quality Assurance (QA) have confirmed that the batch number as 252227. On the same day, half and hour after vaccination, the patient reported that, her arm started to get red and itchy and the patient felt a little weird, hot skin and tingling in lips. No treatment was received. On the same day, the patient had recovered from the events. The reporter assessed the case as non-serious. Follow-up received from the reporter on 09-Nov-2018: The outcome of the events- skin warm, weird feeling, tingling lips and itchy was updated to recovered. The stop date (05-Oct-2018) was added. The narrative was amended accordingly. Significant case amendment (05-Oct-2018): The Seqirus Quality Assurance (QA) have confirmed that the reported batch number as 252227. Hence, the batch number was added in the product tab. The narrative was amended accordingly.
Mom noted the day after vaccines given a rash on both anterior lateral thigh, where vaccines given. Rash was localized to these areas only. Erythematous papular rash. No pruritic, no lesions infant o/w looked well, no fever.
SORE ARM FOR A DAY OR TWO; This spontaneous report received from a patient concerned a 71 year old of unspecified sex. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported) dose was not reported, administered on MAR-2021 for prophylactic vaccination. The batch number was not reported. The Company is unable to perform follow-up to request batch/lot numbers. No concomitant medications were reported. On MAR-2021, the subject experienced sore arm for a day or two. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from sore arm for a day or two on MAR-2021. This report was non-serious.
PER MOTHER, REPORTED TO PHARMACY TODAY 3/3/22 WHILE SHE WAS RECEIVING HER 2ND DOSE OF PFIZER COVID, STATED THAT HER DAUGHTER, BROKE OUT IN RASH ALL OVER HER BODY THE NEXT DAY, HAD DIFFICULT BREATHING, AND BLISTERS ON HER FINGERS AND BETWEEN FINGERS.  MOTHER CALLED HER DOCTOR BUT THEY TOLD HER THAT THEY COULD NOT VERIFY OR VALIDATE HER ALLERGY.  I INFORMED THE MOTHER THAT I WILL FILL OUT THE REPORT FOR HER AND IF SHE BELIEVED THAT HER REACTIONS WERE FROM THE PFIZER COVID VACCINE, THEN SHE WOULD NOT BE ABLE TO GET THE SECOND DOSE.
Tender armpit lymphnodes on side of injection site. Lethargy lasting 96+ hours; Lethargy lasting 96+ hours; This is a spontaneous report from a contactable consumer, the patient. A 32-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ew0151) via an unspecified route of administration in the left arm on 11Apr2021 at 09:45 (at the age of 32-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: er2613) via an unspecified route of administration in the left arm on 21Mar2021 at 09:45(at the age of 32-year-old) as a single dose for COVID-19 immunisation.  Prior to the vaccination, the patient had not been diagnosed with COVID-19. Since the vaccination, the patient had not been been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021 at 11:45, the patient experienced tender armpit lymph nodes on side of injection site and lethargy lasting 96 plus hours. Therapeutic measures were not taken as a result of these events. The clinical outcome of the event tender armpit lymph nodes on side of injection site and lethargy lasting 96 plus hours was recovering at this time of this report.  No follow-up attempts are needed. No further information is expected.
Migraine at 0420 12/24/2020; Body Aches; Joint stiffness; Skin feels hypersensitive especially at injection site.  Took Tylenol and symptoms are better.
Very high blood pressure, heart palpitations.  Visited ER was tested (EKG, Blood tests, chest Xray) no major issues identified.  Following up with my cardiologist
Monday - headache; Tuesday - headache, temp 102F, swelling @ base of neck, occipital; MD dx URI; Given Erythromycin.
HEADACHE; TIREDNESS; ILL FEEL; CHILLS; FEVER; This spontaneous report received from a patient concerned a female of unspecified age. The patient's weight, height, and medical history were not reported. The patient received covid-19 vaccine ad26.cov2.s (suspension for injection, route of admin not reported, batch number: unknown) dose was not reported, administered on 24-MAR-2021 13:50 for prophylactic vaccination. The batch number was not reported and has been requested. No concomitant medications were reported. On 24-MAR-2021, Laboratory data included: Body temperature (NR: not provided) 102 F. On 24-MAR-2021, treatment medications included: paracetamol. On 24-MAR-2021 19:30, the subject experienced ill feel. On 24-MAR-2021 19:30, the subject experienced chills. On 24-MAR-2021 19:30, the subject experienced fever. On 25-MAR-2021, the subject experienced headache. On 25-MAR-2021, the subject experienced tiredness. The action taken with covid-19 vaccine ad26.cov2.s was not applicable. The patient recovered from ill feel, chills, fever, headache, and tiredness on 26-MAR-2021. This report was non-serious.
Initial report was received from a health care professional on 02 September 2011. A 24 year-old female patient with no reported past medical history had received on 21 July 2011 a left deltoid injection of ADACEL, lot number C3935AA and an unspecified amount of time later, experienced a sore arm and had pain when stretching or putting on clothes. The patient first reported this to the reporter on 10 August 2011. She called again on 02 September 2011 to report her sore arm was not improving and she continued to have pain with movement. Treatments were not reported. Concomitant medications included birth control pill. No further information was available at the time of the report. The patient's outcome was not recovered. Documents held by sender: none.
Red mark 05/08/21 about the size of a dime at injection site, 05/09/21 red mark about the size of a quarter in morning  by afternoon red mark the diameter of coffee cup, raised, warm, itchy. Faded over the next 3 days.
Patient received the first dose of Shingrix on 9/21/19. She started having sensation on the left side of upper back on 9/24/19. Patient stated that she had shingles break out on the front and the back of left side of upper torso years back. On 9/25/19, she felt pulsating sensation which intensified with hot and burning  feeling on the following day (9/26/19). She visited doctor's office and was diagnosed with shingles.
On 11/27/2002 it was reported that patient had reaction to DTAP. He developed red area over thighs, swelling had decreased
Reporter experienced flare up of arthritis after receiving the vaccine; Reporter experienced joint pain after receiving the vaccine; This non-serious case was reported by a consumer via sales rep and described the occurrence of flare up of arthritis in a male patient who received RSVPreF3 adjuvanted (Arexvy) for prophylaxis.   On an unknown date, the patient received Arexvy. On an unknown date, an unknown time after receiving Arexvy, the patient experienced flare up of arthritis (Verbatim: Reporter experienced flare up of arthritis after receiving the vaccine) and joint pain (Verbatim: Reporter experienced joint pain after receiving the vaccine).The outcome of the flare up of arthritis and joint pain were resolved (duration 5 days).   It was unknown if the reporter considered the flare up of arthritis and joint pain to be related to Arexvy.   It was unknown if the company considered the flare up of arthritis and joint pain to be related to Arexvy.   Additional Information: GSK Receipt Date: 26-SEP-2023 The reporter experienced flare up of arthritis and joint pain after receiving the Arexvy vaccine. This resolved over the next 5 days. The reporter did not agree to follow up from GlaxoSmithKline.
patient called 1/11/2021 915am inquiring if shingrix had any cough associated reaction.  patient reports developing a dry hacking cough persistent in nature and occurred more when lying down.  cough has decreased since then but still occurs.  pt called is pulmonologist about reaction and informed him no of his current medications cause the side effect.
Systemic: pt had numbness in the elbow no pain a little redness for a few days but pt is still having numbness in arm in elbow area-Severe, Systemic: Numbness (specify: facial area, extremities)-Severe, Additional Details: pt had no pain but numbness in elbow area. he confirmed there was no issue with movement of the arm or restriction and placement of the vaccine was correct not too high in shoulder or too low to affect the radial nerve pt just wanted to report to the vaers to and see if any issues with lot i told him also to go to dr if it gets worse or does not resolve. pt been having the numbness when he touches the arm
dose given at 1620. at 1628 a rash was noted on the pt's arms, abdoment and lower back. she denied, shortness of breath, chest pain, difficulty breathing, swelling or itching in throat/mouth area. Benadryl 25mg given po (liquid) and water at 1629, pt has an epinephrine pen with her due to other allergies, but pt refusing epinephrine at this time. after frequent monitoring, pt, the rash subsided, no shortness of breath, chest pain, swelling in mouth or throat were noted and pt was instructed to call her physician to alert them to her reaction. Instructed pt to call 911 and use Epinephrine if symptoms returned or got worse. Pt did call when she got home at 1755, and stated she felt "fine" that the rash was still not present, she had a headache at this time.
warm to touch; swollen injection site; rash above the injection site; soreness at the site of injection; redness at the site of injection; dizziness; warm to touch; This spontaneous case was reported by a physician and describes the occurrence of DIZZINESS (dizziness), the first episode of VACCINATION SITE WARMTH (warm to touch), the second episode of VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE PAIN (soreness at the site of injection) and VACCINATION SITE ERYTHEMA (redness at the site of injection) in a 56-year-old female patient who received mRNA-1273 (Moderna COVID-19 Vaccine) for COVID-19 vaccination. The occurrence of additional non-serious events is detailed below.     No Medical History information was reported.    On 14-Jan-2021, the patient received first dose of mRNA-1273 (Moderna COVID-19 Vaccine) (unknown route) 1 dosage form. On 14-Jan-2021, the patient experienced DIZZINESS (dizziness), the first episode of VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE PAIN (soreness at the site of injection) and VACCINATION SITE ERYTHEMA (redness at the site of injection). On 25-Jan-2021, the patient experienced the second episode of VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE SWELLING (swollen injection site) and VACCINATION SITE RASH (rash above the injection site). On 14-Jan-2021, DIZZINESS (dizziness) had resolved. On 16-Jan-2021, VACCINATION SITE PAIN (soreness at the site of injection) and VACCINATION SITE ERYTHEMA (redness at the site of injection) had resolved. On 28-Jan-2021, last episode of VACCINATION SITE WARMTH (warm to touch), VACCINATION SITE SWELLING (swollen injection site) and VACCINATION SITE RASH (rash above the injection site) had resolved.        The action taken with mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown) was unknown.   For mRNA-1273 (Moderna COVID-19 Vaccine) (Unknown), the reporter did not provide any causality assessments.   Concomitant medication details were not reported by the reporter. Treatment details was not reported by the reporter.
Admission Date: 9/19/2022 Discharge Date: 9/21/2022  PRESENTING PROBLEM: Asthenia COVID-19   HOSPITAL COURSE: The patient presented to the emergency department on 9/19/22 with complaint of generalized weakness and fevers for the prior 3 days. Also complained of chills, nonproductive cough and sore throat. Chronic diarrhea continued.    During ED course, vital signs and diagnostics were reassuring. CXR was showed no acute findings. COVID-19 was positive. Was on room air. Unfortunately, it was not felt discharging home was appropriate due to lethargy. Family was also not able to care for him due to weakness.   During hospitalization, home medications were continued as appropriate. PT evaluation completed. It was felt that home with home health, RN and PT would be appropriate. He is agreeable.   Today, his normal caregiver is able to care for him and due to improvement in weakness, they are comfortable with his being discharged. He states that he is feeling vastly improved. No shortness of breath, chest pain, dizziness or nausea. We discussed discharge today which he is looking forward to.   The patient is stable for discharge home with home care at this time. He is agreeable with the above plan of care. All questions were answered. Please see discharge instructions for further information.
30 minutes after receiving the vaccine, patient developed a fever, headache and nausea. Took a nap after and symptoms resolved.
c/o pain left arm states has had weakness left arm since injection, Was not seen per physician, States arm pain post each series of Hep B, Reported none on 12/02/02
Pfizer COVID-19 vaccine was given as first dose; Moderna COVID-19 vaccine.  No known adverse reaction.